TownSquare Capital’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-29,084
Closed -$416K 1134
2023
Q2
$416K Buy
29,084
+828
+3% +$11.8K 0.01% 818
2023
Q1
$413K Buy
28,256
+11,510
+69% +$193K 0.01% 745
2022
Q4
$281K Buy
+16,746
New +$290K 0.01% 807
2021
Q4
Sell
-5,628
Closed -$481K 752
2021
Q3
$481K Buy
5,628
+301
+6% +$18.9K 0.01% 463
2021
Q2
$312K Buy
+5,327
New +$271K 0.01% 490

Other funds holding OPRX

TownSquare Capital's OPRX Position: Q3 2023 in Review

TownSquare Capital sold out of OptimizeRx (OPRX) in Q3 2023, closing a stake of 29,084 shares — an estimated $416K sold.

TownSquare Capital first reported a position in OPRX in Q2 2021 and held it in 5 quarters. The position peaked at $481K in Q3 2021. 94 funds tracked by Wall St. Rank hold OPRX as of Q3 2023.

  • TownSquare Capital reported no remaining OptimizeRx position as of Q3 2023 after selling out during the quarter.
  • TownSquare Capital sold 29,084 OptimizeRx shares in Q3 2023, an estimated $416K.
  • TownSquare Capital first reported a position in OptimizeRx in Q2 2021 and held it in 5 quarters.
  • TownSquare Capital's OptimizeRx position peaked at $481K in Q3 2021.
  • 94 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2023.

Based on TownSquare Capital's 13F filing for Q3 2023, filed 15 Nov 2023.